OSSTEC

Osteoarthritis causes chronic pain for 33% of the population and is treated with joint replacement. 1.3M knee replacements are performed globally every year - 450,000 of them are in young patients with high risk of failure and revision surgery. These patients experience poorer outcomes so surgeons are reluctant to treat them. OSSTEC has developed an additive manufacturing bone healing technology, currently applied in partial knee implants. Our implants stimulate long-term bone growth to resolve common sources of failure: loosening and bone loss. Our vision is to keep patients active, pain-free and enjoying added years of improved quality of life

Additive manufacturing,medical devices,and orthopaedics

Osstec operates in the Medical equipment manufacturing industry.

Osstec's revenue is 1m - 10m

Osstec has 11 - 50 employees.